[1. Coppo R, Cattran D. The new oxford clinic-pathological classification of IgA nephropathy. Sec Biol Med Sci. 2010;1:241-8.]Search in Google Scholar
[2. Devarajan P. The use of targeted biomarkers for chronic kidney disease. Adv Chronic Kidney Dis. 2010;17:469-79.10.1053/j.ackd.2010.09.002]Search in Google Scholar
[3. Presta P, Minutolo R. Renin-angiotensin system inhibitors reduce the progression of mesangioproliferative glomerulonephritis: 10-year follow-up. Eur J Intern Med. 2011;22:90-4.10.1016/j.ejim.2011.08.021]Search in Google Scholar
[4. Wright JT, Bakris G, Greene Т. African American study of kidney disease and hypertension study group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA. 2013;288:2421-31.10.1001/jama.288.19.2421]Search in Google Scholar
[5. López-Novoa J, Rodríguez-Peña A, Ortiz A, Martínez-Salgado C, López Hernández F. Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications. Nephrology (Saint-Petersburg). 2013;17(2):9-38.]Search in Google Scholar
[6. Okon K, Sulowicz W, Smolenski O. Interstitial, tubular and vascular factors in progression of rimary glomerulonephritis. Pol J Pathol. 2017;58(2):73-8.]Search in Google Scholar
[7. Nickolas TL, Barasch J, Devarajan P. Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens. 2018;43(22):113-27.]Search in Google Scholar
[8. Schmidt-Ott KM. Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury – where do we stand today? Nephrol Dial Transplant. 2011;26(3):762-4.10.1093/ndt/gfr006]Search in Google Scholar
[9. Ding H, He Y, Li K, Yang J, Li X, Lu, et al. Urinary neutrophil gelatinase-associated lipocalin is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol. 2017; 42:227-34.]Search in Google Scholar
[10. Bolignano D, Coppolino G, Campo S. Urinary neutrophil gelatinase-associated lipocalin is associated with severity of renal disease in proteinuric patients. Nephrol Dial Transplant. 2008;23:414-6.10.1093/ndt/gfm541]Search in Google Scholar
[11. Bolignano D, Lacquaniti A, Coppolino G. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(2):44-237.10.2215/CJN.03530708]Search in Google Scholar
[12. Huang F, Horikoshi S, Kurusu A. Urinary levels of interleukin-18 and disease activity in patients with IgA nephropathy. J Clin Lab Anal. 2011;15(1):30-4.10.1002/1098-2825(2001)15:1<30::AID-JCLA6>3.0.CO;2-X]Search in Google Scholar
[13. Beili S, Ni Z, Cao L, Zhou M. Serum IL-18 Is closely associated with renal tubulointerstitial injury and predicts renal prognosis in IgA Nephropathy. Mediators Inflamm. 2012;2:1-9.]Search in Google Scholar
[14. Shimizu C, Fuijta T, Fuke Y, Ito K, Satomura A, Matsomuto K, Soma M. High circulating levels of the Interleukin-18 binding protein indicate the severity of glomerular involvement in systemic lupus erythematosus. Mod Rheumatol. 2012;22(1):73-9.10.3109/s10165-011-0471-2]Search in Google Scholar